Finance

Lists
ABC:VIE
Cencora Inc
304,60 €
+0,86%
(+2,60) 1D
22 հոկ, 17:36:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABC...
Open
304,70 €
High
306,40 €
Low
303,30 €
Mkt. cap
14,96 մլրդ
Avg. vol.
0,00
Volume
38,00
52-wk high
330,40 €
52-wk low
214,30 €
No. of employees
49 հզր
Open
304,70 €
High
306,40 €
Low
303,30 €
Mkt. cap
14,96 մլրդ
Avg. vol.
0,00
Volume
38,00
52-wk high
330,40 €
52-wk low
214,30 €
No. of employees
49 հզր
News stories
From web sources and news partners
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc
CEORobert Mauch
Employees49 հզր
Founded1871
Headquarters-
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
83,73 մլրդ
85,93 մլրդ
78,36 մլրդ
84,75 մլրդ
Cost of goods sold
80,78 մլրդ
82,87 մլրդ
74,78 մլրդ
81,15 մլրդ
Cost of revenue
80,78 մլրդ
82,87 մլրդ
74,78 մլրդ
81,15 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,75 մլրդ
1,80 մլրդ
1,98 մլրդ
2,13 մլրդ
Operating expense
2,00 մլրդ
2,06 մլրդ
2,23 մլրդ
2,40 մլրդ
Total operating expenses
82,78 մլրդ
84,93 մլրդ
77,01 մլրդ
83,56 մլրդ
Operating income
944,58 մլն
1,00 մլրդ
1,34 մլրդ
1,20 մլրդ
Other non operating income
-49,91 մլն
10,10 մլն
-173,00 հզր
16,88 մլն
EBT including unusual items
-187,04 մլն
708,64 մլն
2,09 մլրդ
996,39 մլն
EBT excluding unusual items
795,23 մլն
941,56 մլն
1,20 մլրդ
1,08 մլրդ
Income tax expense
146,03 մլն
142,51 մլն
459,04 մլն
219,73 մլն
Effective tax rate
-78,07%
20,11%
21,98%
22,05%
Other operating expenses
-4,00 մլն
362,00 հզր
595,00 հզր
881,00 հզր
Net income
-339,70 մլն
559,65 մլն
1,64 մլրդ
763,52 մլն
Net profit margin
-0,41%
0,65%
2,09%
0,90%
Earnings per share
3,84
4,08
4,75
4,48
Interest and investment income
31,52 մլն
20,95 մլն
13,88 մլն
13,82 մլն
Interest expense
-109,36 մլն
-93,36 մլն
-154,34 մլն
-154,52 մլն
Net interest expenses
-77,83 մլն
-72,41 մլն
-140,46 մլն
-140,70 մլն
Depreciation and amortization charges
131,49 մլն
134,29 մլն
132,14 մլն
150,96 մլն
EBITDA
1,21 մլրդ
1,27 մլրդ
1,60 մլրդ
1,47 մլրդ
Gain or loss from assets sale
-
-35,82 մլն
-234,00 հզր
-15,96 մլն
AI content may include mistakes. Learn more
Google Apps